Angiotensin blocking actions of guancydine.
D000804:Angiotensin II / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects*; D002339:Carotid Arteries; D004837:Epinephrine / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006146:Guanidines / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006830:Hydralazine / Q000494:pharmacology; D007022:Hypotension; D007267:Injections; D007668:Kidney / Q000502:physiology; D008297:Male; D009392:Nephrectomy; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012077:Renal Artery; D012083:Renin / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology
D006146:Guanidines; D006584:Hexamethonium Compounds; D010643:Phenoxybenzamine; D000804:Angiotensin II; D006830:Hydralazine; D001285:Atropine; D012110:Reserpine; D011433:Propranolol; D012083:Renin; D009638:Norepinephrine; D004837:Epinephrine; D006145:Guanethidine